Clinicopathological Correlation of Adenoid Cystic Carcinoma: A Notorious Masquerader and Clinical Paradox

Abstract

Background: Adenoid cystic carcinoma (ACC) is an uncommon tumor with nonspecific clinicoradiological features thereby masquerading other nonneoplastic and neoplastic entities. Materials and Methods: Cases of ACC were retrospectively reviewed over a period of 4 years. The clinical details of these patients including fine-needle aspiration cytology (FNAC) and imaging findings were retrieved. Diagnosis was confirmed on histomorphology and supplemented with immunohistochemistry (IHC). Results:: Thirty cases of ACC were included in the study. Mean patient age was 55.5 years with a slight female preponderance. Among the 30 ACCs, 10 (33.4%) were located in submandibular gland, 7 (23.4%) in parotid gland, 6 (20%) in sublingual gland, 2 (6.7%) in lung and one each (3.33%) in nasal cavity, breast, cervix, lip, and skin of face. Preoperative imaging was suggestive of malignancy in 29 cases while a single case of parotid gland ACC was misdiagnosed as benign salivary gland neoplasm. FNAC was performed in 29 cases with a diagnostic accuracy of 82.7%. Histopathological examination showed characteristic features of ACC in all cases with perineural invasion seen in 7 cases. On IHC, positivity for cytokeratin was seen in all cases, cluster of differentiation 117 in 24 cases, thyroid transcription factor-1 in two cases and human epidermal growth factor receptor/neu in two cases. All cases were negative for estrogen receptor and progesterone receptor IHC. Mean Ki-67 score was 47.8%. Conclusion: ACCs are notorious tumors showing slow growth kinetics with propensity for perineural invasion, late recurrences, and distant metastasis. It should be kept in mind as a differential diagnosis at unusual sites other than salivary glands.

Keywords

Adenoid cystic carcinoma - fine-needle aspiration cytology - perineural - salivary glands

Publikationsverlauf

Artikel online veröffentlicht:
17. Juni 2021

• References

• 1 Bonaparte JP, Hart R, Trites J, Taylor MS. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study. J Otolaryngol Head Neck Surg 2008; 37: 642-8
• 2 Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck – A 20 years experience. Int J Oral Maxillofac Surg 2004; 33: 25-31
• 3 Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: A review of chemotherapy and molecular therapies. Oral Oncol 2006; 42: 759-69
• 4 Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984; 54: 1062-9
• 5 Spies JW. Adenoid cystic carcinoma. Arch Surg 1930;21:365-404.
• 6 Jaso J, Malhotra R. Adenoid cystic carcinoma. Arch Pathol Lab Med 2011; 135: 511-5
• 7 Chummun S, McLean NR, Kelly CG, Dawes PJ, Meikle D, Fellows D, Fellows S. et al. Adenoid cystic carcinoma of the head and neck. Br J Plast Surg 2001; 54: 476-80
• 8 Muslimani AA, Ahluwalia MS, Clark CT, Daw HA. Primary adenoid cystic carcinoma of the breast: Case report and review of the literature. Int Semin Surg Oncol 2006; 3: 17
• 8 Muslimani AA, Ahluwalia MS, Clark CT, Daw HA. Primary adenoid cystic carcinoma of the breast: Case report and review of the literature. Int Semin Surg Oncol 2006;3:17.
• 9 Chin S, Kim Z. Adenoid cystic carcinoma of the breast: Report of two cases with immunohistochemical profile of C-kit and MYB overexpression. Indian J Pathol Microbiol 2014; 57: 611-3
• 10 Li N, Xu L, Zhao H, El-Naggar AK, Sturgis EM. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer 2012; 118: 3945-53
• 11 Maheshwari GK, Dave KS, Wadhwa MK, Gopal U, Shah R. Adenoid cystic carcinoma of the uterine cervix with pulmonary metastasis 11 years after radiotherapy: Case report. Turk J Cancer 2000; 30: 181-5
• 12 Grayson W, Taylor LF, Cooper K. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: Comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin. Am J Surg Pathol 1999; 23: 448-58
• 13 Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75: 191-202
• 14 Kumari S, Saugat R, Kapoor A, Paramanandhan M, Soni G, Sirohi P. Adenoid cysticcarcinoma of lung: A very unusual presentation. Int J Sci Rep 2015; 1: 143-5
• 15 Bhalara RV, Gamit MJ, Popat M, Gandhi SH, Dhruva GA. Cytomorphology of primary adenoid cystic carcinoma of lung: An exceedingly rare case. APALM 2015; 2: 223-6
• 16 Batra R, Belaldavar BP. Adenoid cystic carcinoma of the nasal septum: A rare case report. J Sci Soc 2013; 40: 39-40
• 16 Belaldavar BP, Batra R. Adenoid cystic carcinoma of the nasal septum: A rare case report. J Sci Soc 2013;40:39-40.
• 17 Tonev ID, Pirgova YS, Conev NV. Primary adenoid cystic carcinoma of the skin with multiple local recurrences. Case Rep Oncol 2015; 8: 251-5
• 18 Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12: 20-37
• 19 Mehdi I, Shah AH, Moona MS, Verma K, Abussa A, Elramih R, et al. Synchronous and metachronous malignant tumours expect the unexpected. J Pak Med Assoc 2010;60:905-9.
• 20 Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D. Management of adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg 2006; 64: 1114-20
• 21 Norberg-Spaak L, Dardick I, Ledin T. Adenoid cystic carcinoma: Use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 2000; 22: 489-97
• 22 Dy GK, Miller AA, Mandrekar SJ, Aubry MC, Langdon RMJr, Morton RF. Dy GK, Miller AA, Mandrekar SJ, Aubry MC, Langdon RM Jr, Morton RF, et al A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: A CALGB and NCCTG study. Ann Oncol 2005; 16: 1811-6
• 23 Dori S, Vered M, David R, Buchner A. HER2/neu expression in adenoid cystic carcinoma of salivary gland origin: An immunohistochemical study. J Oral Pathol Med 2002; 31: 463-7
• 24 An J, Park S, Sung SH, Cho MS, Kim SC. Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung. Am J Clin Pathol 2014; 141: 721-7
• 25 Giannini PJ, Shetty KV, Horan SL, Reid WD, Litchmore LL. Adenoid cystic carcinoma of the buccal vestibule: A case report and review of the literature. Oral Oncol 2006; 42: 1029-32
• 26 Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 1992; 164: 623-8
• 27 Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD, Vilos GA. et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 2005; 41: 328-35
• 28 da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, de Almeida OP, Kowalski LP. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 2006; 42: 139-46
• 29 Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. et al. Risk factors for local recurrence of adenoid cystic carcinoma: The role of postoperative radiation therapy. Am J Otolaryngol 1999; 20: 281-6
• 30 Pinakapani R, Nallan C, Reddy L, Srujana Y, Mamatha B, Waghray S. Adenoid cystic carcinoma of the head and neck – Literature review. Qual Prim Care 2015; 23: 309-14